Evidence map›Paper›PMID 27746032›Full record

ReviewMolecular genetics and metabolism

Glycosaminoglycans detection methods: Applications of mass spectrometry.

Francyne Kubaski, Harumi Osago, Robert W Mason, Seiji Yamaguchi, Hironori Kobayashi, Mikako Tsuchiya, Tadao Orii, Shunji Tomatsu

Open access · greenAbstract readReview
In one paragraph

Review in Molecular genetics and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 130 citations in OpenAlex.

  1. Identification and Functional Characterization ofInternational journal of molecular sciences · 2019
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. UtilizingAmerican journal of physiology. Cell physiology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Francyne KubaskiNemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA; Department of Biological Sciences, University of Delaware, Newark, DE, USA.
Harumi OsagoDepartment of Biochemistry, Shimane University, Shimane, Japan.
Robert W MasonNemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA; Department of Biological Sciences, University of Delaware, Newark, DE, USA.
Seiji YamaguchiDepartment of Pediatrics, Shimane University, Shimane, Japan.
Hironori KobayashiDepartment of Pediatrics, Shimane University, Shimane, Japan.
Mikako TsuchiyaDepartment of Biochemistry, Shimane University, Shimane, Japan. Electronic address: mikat@med.shimane-u.ac.jp.
Tadao OriiDepartment of Pediatrics, Gifu University, Gifu, Japan.
Shunji TomatsuNemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA; Department of Biological Sciences, University of Delaware, Newark, DE, USA; Department of Pediatrics, Shimane University, Shimane, Japan; Department of Pediatrics, Gifu University, Gifu, Japan. Electronic address: stomatsu@nemours.org.
Shimane University · JPAlfred I. duPont Hospital for Children · USGifu University · JPUniversity of Delaware · USUniversity of Shimane · JP

Funding

Center for Pediatric Research Pilot ProgramP30GM114736 · NIGMS · NEMOURS CHILDREN'S HOSPITAL, DELAWARE · PI SHAFFER, THOMAS H · 2015 to 2019
$5.1M
Newborn Screening and Biomarkers for MucopolysaccharidosesR01HD065767 · NICHD · SAINT LOUIS UNIVERSITY · PI MONTANO, ADRIANA MARIA, TOMATSU, SHUNJI · 2011 to 2015
$2.4M
NICHD NIH HHS R01 HD065767NIGMS NIH HHS P30 GM114736
6 · The paper itself

Abstract

Glycosaminoglycans (GAGs) are long blocks of negatively charged polysaccharides. They are one of the major components of the extracellular matrix and play multiple roles in different tissues and organs. The accumulation of undegraded GAGs causes mucopolysaccharidoses (MPS). GAGs are associated with other pathological conditions such as osteoarthritis, inflammation, diabetes mellitus, spinal cord injury, and cancer. The need for further understanding of GAG functions and mechanisms of action boosted the development of qualitative and quantitative (alcian blue, toluidine blue, paper and thin layer chromatography, gas chromatography, high pressure liquid chromatography, capillary electrophoresis, 1,9-dimethylmethylene blue, enzyme linked-immunosorbent assay, mass spectrometry) techniques. The availability of quantitative techniques has facilitated translational research on GAGs into the medical field for: 1) diagnosis, monitoring, and screening for MPS; 2) analysis of GAG synthetic and degradation pathways; and 3) determination of physiological and pathological roles of GAGs. This review provides a history of development of GAG assays and insights about the use of tandem mass spectrometry and its applications for GAG analysis.

Indexed as

Chromatography, Thin LayerEarly DiagnosisGlycosaminoglycansHumansMucopolysaccharidosesTandem Mass SpectrometryTranslational Research, BiomedicalGlycosaminoglycansAlcian blueChromatography, mucopolysaccharidosesELISAGlycosaminoglycansMass spectrometry

Identifiers

PMID27746032
PMCPMC5477676
OpenAlexW2526629344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.